Answers are grounded in this paper and cite their sources.
Study integrates genomic testing into clinical pathways, suggesting improved patient outcomes in Singapore.
The Clinical Implementation Pilots (CIPs) within Singapore’s National Precision Medicine (NPM) programme are designed to integrate genomic testing into clinical pathways for conditions including hereditary cancers, familial hypercholesterolemia, breast cancer, primary glomerular disease, and pharmacogenomics. These multidisciplinary pilots emphasize collaboration to enhance cost-effectiveness and improve patient outcomes, thereby establishing a sustainable foundation for future scalability in clinical genomics and ultimately fostering a healthier population through personalized healthcare solutions.
No takes yet. Share an insight, caveat, or question.
Caeser et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: